The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990Cambridge University Press, 1997 - 258 Seiten How do we evaluate the safety and benefit of new drugs? What tasks do we hold the government responsible for and which ones do we leave to the medical profession? Harry Marks explores the origins of our contemporary system of drug regulation and the modern clinical trial. He shows that the story of modern drug regulation is synonymous with the history of therapeutic reform. Accompanying this history of public policy is a detailed account of changing experimental ideal and practices. Marks follows the history of therapeutic experimentation, from the 'collective investigations' of the last century to the controlled clinical trial which emerged after 1950 as the paradigm of scientific experimentation. The result is the first general history of clinical research in the United States, a book which examines therapeutic experiments in a wide range of diseases, from syphilis and pneumonia to heart disease and diabetes. |
Inhalt
A rational therapeutics | 17 |
Memories of underdevelopment Therapeutic research in the United States 19001935 | 42 |
Playing it safe The Federal Food Drug and Cosmetic Act of 1938 | 71 |
War and peace | 98 |
Of methods and institutions or The triumph of statistics | 129 |
Managing chance Statistics and therapeutic experiments 19501960 | 136 |
You gotta have heart | 164 |
Anatomy of a controversy The University Group Diabetes Program study | 197 |
The dreams of reason Retrospect and prospect | 229 |
A NOTE ON SOURCES | 249 |
INDEX | 251 |
Andere Ausgaben - Alle anzeigen
The Progress of Experiment: Science and Therapeutic Reform in the United ... Harry M. Marks Keine Leseprobe verfügbar - 1997 |
The Progress of Experiment: Science and Therapeutic Reform in the United ... Harry M. Marks Keine Leseprobe verfügbar - 1997 |
Häufige Begriffe und Wortgruppen
Administration American Ancel Keys Archives arsphenamine Arteriosclerosis Atherosclerosis Bulletin Cambridge cardiovascular cholesterol clinical investigators clinical research Clinical Trials clinicians Committee Commonwealth Fund Controlled Clinical Trials cooperative studies Cornfield Coronary Council on Pharmacy critics December Diabetes diet Diet-Heart study dietary discussion Earle Moore effects epidemiological evaluation experiment experimental FDA officials FDA's February Federal Fisher Food and Drug heart disease History Hospital idem Institute insulin J. J. Durrett JAMA January Johns Hopkins June Klumpp laboratory manufacturers March Medical Research Medical Sciences Medicine Memorandum of Interview National November October oral hypoglycemic Page papers patients penicillin Pharmacology Pharmacy and Chemistry physicians Pneumonia political practice practitioners problem Public Health R. A. Fisher randomized Report Rufus Cole scientific social Sollman Stamler statisticians streptomycin Sulfanilamide sulfapyridine syphilis therapeutic reformers Therapeutic Trials Therapy tolbutamide Tuberculosis UGDP UGDP's University Press Venereal Diseases W-NRC York

